Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2021
Healthcare Utilization and End-of-Life Outcomes in Patients Receiving CAR T-Cell TherapyP Connor Johnson, Caron Jacobson, Alisha Yi, et al.
British Journal of Haematology|January 3, 2013
Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography eraPhilippe Armand, Sarah Welch, Haesook T Kim, et al.
Science Advances|September 18, 2024
Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive toolJulia Fröse, Jennifer Rowley, Ali Salehi Farid, et al.
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
Transplantation and Cellular Therapy|November 9, 2025
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy StudiesFrederick L Locke, Sarah Nikiforow, Matthew J Frigault, et al.
Hematological Oncology|June 29, 2023
Cellular therapy in lymphomaAnna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
British Journal of Haematology|January 6, 2016
A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphomaPhilippe Armand, Robert Redd, Jad Bsat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin LymphomasAjay K Gopal, Ronald Levy, Roch Houot, et al.
Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.
Blood|October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphomaCaron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Pageof 4